Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Platzer in conjunction with its acquisition of NCC’s share in Kineum
Mandate

Vinge advises Platzer in conjunction with its acquisition of NCC’s share in Kineum

December 21, 2022

Vinge has advised Platzer in conjunction with the acquisition of NCC’s share in Kineum – a 27 storey high destination building in Gårda, Gothenburg. The project, which was commenced in 2018, has been implemented by Platzer and NCC in a joint venture company.

As a result of the transaction, Platzer has become the sole owner of Kineum. Vinge’s team primarily consisted of Olof Jisland and Kristoffer Larson. 

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

 Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024